Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bayer

Showing results (1-10 of 825) with videos related to

Pageof 83
Sort By:
Fortschritte Der Medizin|May 28, 1981
[Risk analysis in nuclear technics. German risk study of nuclear power plants]A Bayer
Zentralblatt Fur Veterinarmedizin. Reihe A|April 1, 1973
[Motion analysis in trotting horses using ungulography]A Bayer
Berliner Und Munchener Tierarztliche Wochenschrift|November 1, 1970
[Usefulness of the working pulse frequency as a criteria for the performance of trotting horses]A Bayer
Fortschritte Der Medizin|December 3, 1981
[The "limit-exceeding risk" in nuclear technics. Supplement to the article "Risk analysis in nuclear technics"]A Bayer
Molecular Psychiatry|December 9, 2021
Pyroglutamate Aβ cascade as drug target in Alzheimer's diseaseThomas A Bayer
The Journal of Comparative Neurology|March 1, 1980
Development of the hippocampal region in the rat. I. Neurogenesis examined with 3H-thymidine autoradiographyS A Bayer
Frontiers in Aging Neuroscience|September 7, 2021
N-Truncated Aβ Starting at Position Four-Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer's DiseaseThomas A Bayer
The Journal of Comparative Neurology|January 1, 1979
The development of the septal region in the rat. II. Morphogenesis in normal and x-irradiated embryosS A Bayer
Environmental Microbiology Reports|October 19, 2016
Cellulosomes and designer cellulosomes: why toy with Nature?Edward A Bayer
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 7, 2013
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?Thomas A Bayer
Pageof 83

Showing results (1-10 of 825) with videos related to

Sort By:
Pageof 83
Fortschritte Der Medizin|May 28, 1981
[Risk analysis in nuclear technics. German risk study of nuclear power plants]A Bayer
Zentralblatt Fur Veterinarmedizin. Reihe A|April 1, 1973
[Motion analysis in trotting horses using ungulography]A Bayer
Berliner Und Munchener Tierarztliche Wochenschrift|November 1, 1970
[Usefulness of the working pulse frequency as a criteria for the performance of trotting horses]A Bayer
Fortschritte Der Medizin|December 3, 1981
[The "limit-exceeding risk" in nuclear technics. Supplement to the article "Risk analysis in nuclear technics"]A Bayer
Molecular Psychiatry|December 9, 2021
Pyroglutamate Aβ cascade as drug target in Alzheimer's diseaseThomas A Bayer
The Journal of Comparative Neurology|March 1, 1980
Development of the hippocampal region in the rat. I. Neurogenesis examined with 3H-thymidine autoradiographyS A Bayer
Frontiers in Aging Neuroscience|September 7, 2021
N-Truncated Aβ Starting at Position Four-Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer's DiseaseThomas A Bayer
The Journal of Comparative Neurology|January 1, 1979
The development of the septal region in the rat. II. Morphogenesis in normal and x-irradiated embryosS A Bayer
Environmental Microbiology Reports|October 19, 2016
Cellulosomes and designer cellulosomes: why toy with Nature?Edward A Bayer
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 7, 2013
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?Thomas A Bayer
Pageof 83